The cognitive benefits of galantamine are sustained for at least 36 months: A long-term extension trialRASKIND, Murray A; PESKIND, Elaine R; TRUYEN, Luc et al.Archives of neurology (Chicago). 2004, Vol 61, Num 2, pp 252-256, issn 0003-9942, 5 p.Article

Effect of galantamine on verbal repetition in AD : A secondary analysis of the VISTA trialROCKWOOD, Kenneth; FAY, Sherri; JARRETT, Pamela et al.Neurology. 2007, Vol 68, Num 14, pp 1116-1121, issn 0028-3878, 6 p.Article

Metabolic patterns associated with the clinical response to galantamine therapy : A fludeoxyglucose F 18 positron emission tomographic studyMEGA, Michael S; DINOV, Ivo D; PORTER, Verna et al.Archives of neurology (Chicago). 2005, Vol 62, Num 5, pp 721-728, issn 0003-9942, 8 p.Article

Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivationSOBRADO, Monica; RODA, José M; LOPEZ, Manuela G et al.Neuroscience letters. 2004, Vol 365, Num 2, pp 132-136, issn 0304-3940, 5 p.Article

Nicotinic receptors and Alzheimer's diseaseBOURIN, Michel; RIPOLL, Nadège; DAILLY, Eric et al.Current medical research and opinion. 2003, Vol 19, Num 3, pp 169-177, issn 0300-7995, 9 p.Article

Reversible Pisa syndrome (Pleurothotonus) due to the cholinesterase inhibitor galantamine: Case reportCOSSU, Giovanni; MELIS, Maurizio; MELIS, Giannina et al.Movement disorders. 2004, Vol 19, Num 10, pp 1243-1244, issn 0885-3185, 2 p.Article

Galantamine inhibits calpain―calcineurin signaling activated by beta-amyloid in human neuroblastoma SH-SY5Y cellsQIANQIAN LI; JING FANG; MEIMEI YANG et al.Neuroscience letters. 2010, Vol 480, Num 3, pp 173-177, issn 0304-3940, 5 p.Article

Effects of galantamine on L-NAME-induced behavioral impairment in Y-maze task in miceTANAKA, Ken-Ichi; TAKAO YAGI; SHIMAKOSHI, Ryosuke et al.Neuroscience letters. 2009, Vol 462, Num 3, pp 235-238, issn 0304-3940, 4 p.Article

Galantamine is an allosterically potentiating ligand of the human α4/β2 nAChRSAMOCHOCKI, M; ZERLIN, M; JOSTOCK, R et al.Acta neurologica Scandinavica. Supplementum. 2000, Vol 102, Num 176, pp 68-73, issn 0065-1427Conference Paper

L'INFLUENCE DE LA NIVALINE SUR L'ELECTROENCEPHALOGRAMME DANS LES CONDITIONS DE L'HYPOXIEKISELKOVA EV.1975; FARMACIJA; BALG.; DA. 1975; VOL. 25; NO 1; PP. 31-34; ABS. RUSSE ANGL.; BIBL. 6 REF.Article

Safety and efficacy of galantamine in subjects with mild cognitive impairmentWINBLAD, B; GAUTHIER, S; SCINTO, L et al.Neurology. 2008, Vol 70, Num 22, pp 2024-2035, issn 0028-3878, 12 p., 1Article

Bullous Pemphigoid Precipitated by Galantamine HydrobromideDIAB, Mohammad; COLOE, Jacquelyn; BECHTEL, Mark A et al.Cutis (New York, NY). 2009, Vol 83, Num 3, pp 139-140, issn 0011-4162, 2 p.Article

The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6BACHUS, R; BICKEL, U; THOMSEN, T et al.Pharmacogenetics (London). 1999, Vol 9, Num 6, pp 661-668, issn 0960-314XArticle

Reduced resource consumption through three generations of Galantamine.HBr synthesisVAN DER VORST, Geert; AELTERMAN, Wim; DE WITTE, Bruno et al.Green chemistry (Print). 2013, Vol 15, Num 3, pp 744-748, issn 1463-9262, 5 p.Article

PRELIMINARY EXPERIMENTS WITH GALANTHAMINE HYDROBROMIDE ON DEPRESSED RESPIRATION = EXPERIMENTATIONS PRELIMINAIRES AVEC L'HYDROBROMIDE DE GALANTHAMINE SUR LA DEPRESSION RESPIRATOIRECOZANITIS DA; ROSENBERG P.1974; ANAESTHESIST; DTSCH.; DA. 1974; VOL. 23; NO 7; PP. 302-305; ABS. ALLEM.; BIBL. 5 REF.Article

SULL'AZIONE DELLA NIVALINA SUL MUSCOLO COSTRITTORE ISOLATO DELL'IRIDE = ACTION DE LA NIVALINE SUR LE MUSCLE CONSTRICTEUR ISOLE DE L'IRISSTEINDLER P.1972; MINERVA OFTALMOL.; ITAL.; DA. 1972; VOL. 14; NO 3; PP. 132-134; ABS. ANGL.; BIBL. 7REF.Serial Issue

ELECTROENCEPHALOGRAPHIC AND BLOOD CHEMISTRY RESPONSES TO GALANTHAMINE HYDROBROMIDE IN EPILEPTIC VOLUNTEERSCOZANITIS D; TOIVAKKA E; DESSYPRIS A et al.1973; ANAESTHESIST; DTSCH.; DA. 1973; VOL. 22; NO 1; PP. 31-33; ABS. ALLEM.; BIBL. 8REF.Serial Issue

Galantamine inhibits |3-amyloid aggregation and cytotoxicityMATHARU, Balpreet; GIBSON, Gillian; PARSONS, Richard et al.Journal of the neurological sciences. 2009, Vol 280, Num 1-2, pp 49-58, issn 0022-510X, 10 p.Article

GALANTHAMINE EN TANT QU'ANTAGONISTE DE SUCCINYLCHOLINE ET TUBOCURARINE CHEZ LES MALADES ONCOLOGIQUESGADALOV VP; KHMELEVSKIJ YA M.1974; VEST. AKAD. MED. NAUK S.S.S.R.; S.S.S.R.; DA. 1974; NO 12; PP. 13-19; ABS. ANGL.; BIBL. 1/2P.Article

LEUCOIUM VERNUM, SOURCE DE GALANTAMINEKOHLMUENZER S; CYUNEL E.1972; IN: POSTEP DZIEDZINIE LEKU ROSL. MATER. SYMP. POZNAN, 1970; POZNAN; HERBA POLONICA; DA. 1972; PP. 109-114; ABS. RUSSE ANGL.; BIBL. 19REF.Conference Proceedings

Protective effects of galantamine against Aβ-induced PC12 cell apoptosis by preventing mitochondrial dysfunction and endoplasmic reticulum stressXIAOYU LIU; KEDI XU; MING YAN et al.Neurochemistry international. 2010, Vol 57, Num 5, pp 588-599, issn 0197-0186, 12 p.Article

Efficacy and safety of galantamine in patients with dementia with Lewy bodies: A 12-week interim analysisEDWARDS, Keith R; HERSHEY, Linda; WRAY, Laura et al.Dementia and geriatric cognitive disorders. 2004, Vol 17, pp 40-48, issn 1420-8008, 9 p., SUP1Article

Galantamine-ER For Cognitive Dysfunction In Bipolar Disorder and Correlation with Hippocampal Neuronal Viability: A Proof-of-Concept StudyLOSIFESCU, Dan V; MOORE, Constance M; DECKERSBACH, Thilo et al.CNS neuroscience & therapeutics (Print). 2009, Vol 15, Num 4, pp 309-319, issn 1755-5930, 11 p.Article

Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: A review based on meta-analyses by the Cochrane collaborationKURZ, A; VAN BAELEN, B.Dementia and geriatric cognitive disorders. 2004, Vol 18, Num 2, pp 217-226, issn 1420-8008, 10 p.Article

LA SUCCESSION DE LA DECURARISATION DES DIVERS GROUPES DE MUSCLE DU SQUELETTE LORS DE L'UTILISATION D'ANTAGONISTES DES MYORELAXANTSFISENKO VP; MITSOV V.1975; FARMAKOL. I TOKSIKOL.; S.S.S.R.; DA. 1975; VOL. 38; NO 1; PP. 34-38; ABS. ANGL.; BIBL. 1/2P.Article